Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04733911
Other study ID # Recovery-Eccentrics-UTH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date April 30, 2022

Study information

Verified date June 2022
Source University of Thessaly
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study will be to investigate the recovery kinetics of neuromuscular fatigue, muscle microtrauma indicators, performance and oxidative stress factors after three different exercise induced muscle damage (EIMD) protocols in adult Males. Also, this study will determine the comparison among three different eccentric protocols in neuromuscular fatigue, muscle microtrauma indicators, performance and oxidative stress factors. The eccentric protocols will be differentiated in training volume and specifically in the eccentric repetitions in isokinetic dynamometer.


Description:

It is known that eccentric exercise induces muscle microtrauma. Also, eccentric type of exercise are associated with inflammatory response. The leukocytes and the immune cells during the phagocytosis process alter the redox status causing secondary muscle damage to the muscle tissue and also increase oxidative stress concentration. Despite of the existence of studies that examine the muscle damage indicators, inflammatory response, performance and neuromuscular fatigue and oxidative stress concentrations after eccentric exercise, however no studies are detected in order to compare the differences among three eccentric protocols. The eccentric protocols will be differentiated in training volume and specifically in the eccentric repetitions in isokinetic dynamometer. Specifically, a randomized, fourth-trial, cross-over, repeated measures design will be applied. Healthy male adults (age 18-30 years) will participate in the present study. Also, it is considered necessary that the participants will not suffer from any musculoskeletal injuries that will limit their ability to perform the exercise protocols. Also the participants will not be smokers and will not consume alcohol and nutritional supplements. In the first phase all participants will sign an informed consent form after they will be informed about all benefits and risks of this study and they will sign a recent historical of musculoskeletal injury or illness form. Subsequently, fasting blood samples will be collected by venipuncture using a disposable needle (20-gauge) in order to measure muscle damage markers (CK), inflammation markers (WBC) and oxidative stress markers (TBARS, PC, GSH, ΤΑC, CAT, UA). After, delayed onset muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs, body weight (BW), height and body composition (DXA method) will be measured in the lab. Completing the first phase, participants will be instructed by a dietitian how to record a 5 days diet recalls estimating the energy intake during the trials will be the same. The knee range of motion (KJRM) will be determined by the use of a goniometer, 24 hours after (second phase). The counter movement jump (CMJ) will be evaluated on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus medialis (VM) and vastus lateralis muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. The peak eccentric and concentric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Also, the isometric peak torque of the knee extensors will be evaluated at 65° in both limbs. Finally, Open-circuit spirometry will be utilized for assessment of maximal oxygen consumption (VO2max) using an automated online pulmonary gas exchange system via breath-by-breath analysis during a graded exercise testing on a treadmill. 96 hours after, the participants are going to perform one of the three eccentric protocols randomly, on an isokinetic dynamometer. The eccentric protocol will be performed on a different limb for each trial. The ECC 75 trial will include 75 eccentric maximum repetitions (5 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The ECC 150 trial will include 150 eccentric maximum repetitions (10 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The ECC 300 trial will include 300 eccentric maximum repetitions (20 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The DOMS indicator in the knee flexors (KF) and extensors (KE) of both limbs and the KJRM will be evaluated immediately after each protocol. Also, the (CMJ) will be evaluated on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus medialis (VM) and vastus lateralis muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. In addition, the peak eccentric and concentric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60o/sec. Also, the isometric peak torque of the knee extensors will be evaluated at 65o in both limbs. All the above markers will be evaluated 24, 48 and 192 hours post eccentric protocol, however at these time points, fasting blood samples (20ml) will be collected in order to estimate hematological and biochemical indicators. Α 2 - week washout period will be adapted among trials. After, the participants will perform the process until they complete the trials.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 30, 2022
Est. primary completion date February 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Aged between 18 and 30 years - Body Mass Index between 18.5-24.9 kg/m*m - Free of chronic diseases - Free of musculoskeletal injury - participants should be non-smokers Exclusion Criteria: - Musculoskeletal injury - Chronic disease - Use of alcohol, caffeine and any type of nutritional supplements or medication before (= 6 months) and throughout the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
75 eccentric contractions
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 5 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.
150 eccentric contractions
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 10 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.
300 eccentric contractions
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 20 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.

Locations

Country Name City State
Greece University o Thessaly, School of Physical Education and Sports Science Tríkala

Sponsors (1)

Lead Sponsor Collaborator
University of Thessaly

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in white blood cell count White blood cell count will be measured using an automatic blood analyzer At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in catalase activity Concentration of catalase will be measured in red blood cells At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in uric acid in plasma concentration of uric acid will be measured in plasma At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in protein carbonyls in blood Concentration of protein carbonyls will be measured in red blood cells At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in total antioxidant capacity total antioxidant capacity will be measured in serum At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in reduced glutathione in blood Concentration of oxidized glutathione will be measured in red blood cells At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in thiobarbituric acid reactive substances Thiobarbituric acid will be measured in plasma At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in Creatine kinase in blood Creatine kinase will be measured in plasma At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in countermovement jump height Countermovement jump height will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in ground reaction force (GRF) during countermovement jump test The ground reaction force will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the GRF data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in peak power during countermovement jump test The peak power will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the peak power data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in mean power during countermovement jump test The mean power will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the mean power data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in vertical stifness during countermovement jump test The vertical stiffness will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of vertical stifness data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in peak rate of force develpemnt during countermovement jump test The Peak rate of force development will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the Peak RFD data for each leg. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in peak normalized EMG during the eccentric and concentric phases of the counter movement jump Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus medialis (VM) and vastus lateralis muscles. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in mean normalized EMG during the eccentric and concentric phases of the counter movement jump Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus medialis (VM) and vastus lateralis muscles. At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in knee range of motion Knee range of motion will be measured by goniometer At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in eccentric isokinetic knee extensors peak torque Eccentric isokinetic knee extensors peak torque will be assessed on an isokinetic dynamometer At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in concentric isokinetic knee extensors peak torque Concentric isokinetic knee extensors peak torque will be assessed on an isokinetic dynamometer At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in eccentric isokinetic knee flexors peak torque Eccentric isokinetic knee flexors peak torque will be assessed on an isokinetic dynamometer At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in concentric isokinetic knee flexors peak torque Concentric Iisokinetic knee flexors peak torque will be assessed on an isokinetic dynamometer At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in isometric peak torque The isometric peak torque will be assessed on an isokinetic dyanmometer At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in fatigue index of isometric torque during 10 second Fatigue rate during MVIC will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-secong maximal isometric contraction. At baseline, 1hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Primary Change in delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs Muscle soreness (KF and KE) will be assessed during palpation of the muscle belly and the distal region At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
Secondary Body weight Body weight will be measured on a beam balance with stadiometer At baseline
Secondary Body height Body height will be measured on a beam balance with stadiometer At baseline
Secondary Body fat Body fat will be measured by using Dual-emission X-ray absorptiometry At baseline
Secondary Dietary intake Dietary intake will be assessed using 5 -day diet recalls Over a 5 -day period at baseline
Secondary Maximal oxygen consumption (VO2max) Maximal oxygen consumption will be measured by open circuit spirometry via breath by breath method At baseline
See also
  Status Clinical Trial Phase
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Unknown status NCT02280668 - Investigating Muscle Repair in Response to Icing Therapy Post Eccentric Muscle Damage Exercise N/A
Recruiting NCT03766815 - Effect of Branched-chain Amino Acid Supplementation on Muscle Damage N/A
Completed NCT04315077 - The Short Term Effects of Oceanix Supplementation on Recovery N/A
Completed NCT03313388 - Tart Cherry Juice for Exercise Performance and Recovery N/A
Completed NCT03753321 - Whey and Soy Protein Supplementation in Football Players N/A
Recruiting NCT06334224 - Acute Physiological Responses to Twice Daily Blood Flow Restriction Training N/A
Recruiting NCT03707067 - Compression Garments for Recovery in Modern Pentathletes N/A
Completed NCT03707470 - Made to Measure Compression Garments for Recovery in Rugby Players N/A
Completed NCT05037942 - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise N/A
Completed NCT05100459 - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals N/A
Recruiting NCT04549610 - HMB and Exercise-induced Muscle Damage Phase 2/Phase 3
Completed NCT05804604 - Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Completed NCT05011643 - Exercise-induced Muscle Damage in Statin Users
Completed NCT01827696 - Effect of American Ginseng on Exercise-induced Muscle Soreness Phase 1
Completed NCT01728675 - Eccentric Exercise and Oxidative Stress N/A
Completed NCT03527797 - Diaphragm Protective Ventilation in the Intensive Care Unit N/A
Withdrawn NCT05044936 - Topical Cannabidiol Cream and Post-exercise Recovery Early Phase 1
Completed NCT04679519 - The Effects of Protein Supplementation in Females and Males Following Acute Eccentric Exercise N/A